Daniel Markowitz
Stock Analyst at Evercore ISI Group
(1.15)
# 3,636
Out of 4,944 analysts
6
Total ratings
50%
Success rate
-7.14%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Initiates: Outperform | $170 | $159.81 | +6.38% | 1 | Jul 28, 2025 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $275 → $350 | $239.90 | +45.89% | 2 | Jul 25, 2025 | |
| RGEN Repligen | Maintains: In-Line | $140 → $130 | $121.40 | +7.08% | 2 | Jul 8, 2025 | |
| TECH Bio-Techne | Initiates: Outperform | $75 | $52.83 | +41.96% | 1 | Mar 18, 2025 |
Natera
Jul 28, 2025
Initiates: Outperform
Price Target: $170
Current: $159.81
Upside: +6.38%
West Pharmaceutical Services
Jul 25, 2025
Maintains: Outperform
Price Target: $275 → $350
Current: $239.90
Upside: +45.89%
Repligen
Jul 8, 2025
Maintains: In-Line
Price Target: $140 → $130
Current: $121.40
Upside: +7.08%
Bio-Techne
Mar 18, 2025
Initiates: Outperform
Price Target: $75
Current: $52.83
Upside: +41.96%